New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

about

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

Item

http://www.wikidata.org/entity/Q46571812

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@en

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@nl

type

Item

label

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@en

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@nl

prefLabel

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@en

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@nl

P1476

New Hydroxyquinoline-Based Derivatives as Potent Modulators of Amyloid-β Aggregations.

@en

P2093

Chin-Lan Fu

http://www.w3.org/2001/XMLSchema#string

Li-Shin Hsu

http://www.w3.org/2001/XMLSchema#string

Ming-Kuan Hu

http://www.w3.org/2001/XMLSchema#string

Yung-Feng Liao

http://www.w3.org/2001/XMLSchema#string

P2860

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Tau reduction prevents Abeta-induced defects in axonal transport.

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Computational methods for the prediction of 'drug-likeness'

Eph receptors: new players in Alzheimer's disease pathogenesis.

Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.

New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.

Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation

The redox chemistry of the Alzheimer's disease amyloid beta peptide.

Metal ions, Alzheimer's disease and chelation therapy.

P304

327-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ARDP.201500453

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27027880

http://www.w3.org/2001/XMLSchema#string